Predicting pathologic nodal response following neoadjuvant chemotherapy for invasive breast cancer utilizing sequential axillary nodal imaging techniques

被引:0
|
作者
Ferstenberg, Marielle [1 ]
Anderson, Stewart [2 ]
Cowher, Michael [3 ]
Krupa, Kristin [4 ]
Krupa, Kelly [4 ]
Julian, Thomas [4 ]
机构
[1] Allegheny Hlth Network, Wexford, PA USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] West Virginia Univ, Morgantown, WV 26506 USA
[4] Allegheny Hlth Network, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
580846
引用
收藏
页码:73 / 73
页数:1
相关论文
共 50 条
  • [21] Pathologic response and survival efficacy in patients with initial nodal involvement after neoadjuvant chemotherapy in early breast cancer
    Morales Murillo, S.
    Gasol Cudos, A.
    Veas Rodriguez, J.
    Vilardell Villellas, F.
    Sanchez Guzman, D-R.
    Canosa Morales, C.
    Mele Olive, J.
    el Koulali, I.
    Iglesias Martinez, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Role of Oncotype DX® recurrence score in predicting nodal response after neoadjuvant chemotherapy in breast cancer
    Mele, Alessandra
    Alapati, Amulya
    James, Ted
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 172 - 172
  • [23] Neoadjuvant Chemotherapy for Breast Cancer: Does Pretreatment Axillary Nodal Staging Improve Decision Making?
    Charalabos Batsis
    Dimosthenis Ziogas
    Michael Fatouros
    Annals of Surgical Oncology, 2009, 16 : 1063 - 1064
  • [24] Neoadjuvant Chemotherapy for Breast Cancer: Does Pretreatment Axillary Nodal Staging Improve Decision Making?
    Batsis, Charalabos
    Ziogas, Dimosthenis
    Fatouros, Michael
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (04) : 1063 - 1064
  • [25] PREDICTIVE VARIABLES FOR PATHOLOGIC COMPLETE RESPONSE FOLLOWING NEOADJUVANT CHEMOTHERAPY IN PRIMARY INVASIVE BREAST CANCER
    Vanoppen, M.
    Brouckaert, O.
    Laenen, A.
    Wildiers, H.
    Leunen, K.
    Amant, F.
    Berteloot, P.
    Floris, G.
    Vergote, I.
    Neven, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [26] Axillary pathologic response after neoadjuvant chemotherapy in locally advanced breast cancer with axillary involvement
    Jimenez-Ballve, A.
    Serrano-Palacio, A.
    Garcia-Saenz, J. A.
    Ortega Candil, A.
    Salsidua-Arroyo, O.
    Roman-Santamaria, J. M.
    Pelayo Alarcon, A.
    Fuentes Ferrer, M. E.
    Carreras-Delgado, J. L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2015, 34 (04): : 230 - 235
  • [27] Can ultrasound or MRI correctly determine the axillary response after neoadjuvant chemotherapy in patients with breast cancer and nodal invasion?
    Lamerant, Sarah
    Mackens, Shari
    Labaisse, Marie-Anne
    Renard, Nathalie
    Jouret, Mathieu
    IMAGERIE DE LA FEMME, 2018, 28 (04) : 215 - 225
  • [28] Factors accounting for low nodal counts in axillary dissection following neoadjuvant chemotherapy
    Casas-Balazote, A.
    Vernet-Tomas, M.
    Lopez-Yarto, M.
    Soler, J.
    Tusquets, I.
    Segura, M.
    Corominas, J.
    Carreras, R.
    EJC SUPPLEMENTS, 2008, 6 (07): : 215 - 216
  • [29] Contralateral axillary nodal involvement from invasive breast cancer
    Kiluk, John V.
    Prowler, Vanessa
    Lee, M. Catherine
    Khakpour, Nazanin
    Laronga, Christine
    Cox, Charles E.
    BREAST, 2014, 23 (03): : 291 - 294
  • [30] Biomarkers Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
    Li, Xiaoxian Bill
    Krishnamurti, Uma
    Bhattarai, Shristi
    Ktimov, Sergey
    Reid, Michelle D.
    O'Regan, Ruth
    Aneja, Ritu
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (06) : 871 - 878